Clinical Trial Update: Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of gemcitabine, carboplatin, and lenalidomide in patients with advanced or metastatic urothelial cancer and ot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer of the Urethra
• Urothelial Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Urethral Neoplasms, Neoplasms, Urethral | Phase 1 | Status: COMPLETED